These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25029513)

  • 41. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
    King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Performance of Kidney Volume Measurement for Polycystic Kidney Disease: A Comparative Study of Ellipsoid vs. Manual Segmentation.
    Shi B; Akbari P; Pourafkari M; Iliuta IA; Guiard E; Quist CF; Song X; Hillier D; Khalili K; Pei Y
    Sci Rep; 2019 Jul; 9(1):10996. PubMed ID: 31358787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. nnUNet for Automatic Kidney and Cyst Segmentation in Autosomal Dominant Polycystic Kidney Disease.
    Krishnan C; Schmidt E; Onuoha E; Mrug M; Cardenas CE; Kim H
    Curr Med Imaging; 2024; 20():1-9. PubMed ID: 38389364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging.
    Turco D; Severi S; Mignani R; Aiello V; Magistroni R; Corsi C
    Acad Radiol; 2015 Nov; 22(11):1376-84. PubMed ID: 26276168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease.
    Siedek F; Grundmann F; Weiss K; Pinto Dos Santos D; Arjune S; Haneder S; Persigehl T; Müller RU; Baessler B
    Invest Radiol; 2020 Apr; 55(4):217-225. PubMed ID: 31876626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging.
    Akbari P; Nasri F; Deng SX; Khowaja S; Lee SH; Warnica W; Lu H; Rattansingh A; Atri M; Khalili K; York P
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):827-834. PubMed ID: 35383043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
    O'Neill WC; Robbin ML; Bae KT; Grantham JJ; Chapman AB; Guay-Woodford LM; Torres VE; King BF; Wetzel LH; Thompson PA; Miller JP
    Am J Kidney Dis; 2005 Dec; 46(6):1058-64. PubMed ID: 16310571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study.
    Lai S; Perrotta AM; Panebianco V; Mazzaferro S; Menè P; Pellicano C; Tinti F; Muscaritoli M; Cianci R; Gigante A
    Int Urol Nephrol; 2023 Dec; 55(12):3153-3158. PubMed ID: 37043156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.
    Muto S; Kawano H; Isotani S; Ide H; Horie S
    Clin Exp Nephrol; 2018 Jun; 22(3):583-590. PubMed ID: 29101551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatments to slow progression of autosomal dominant polycystic kidney disease: systematic review and meta-analysis of randomized trials.
    Myint TM; Rangan GK; Webster AC
    Nephrology (Carlton); 2014 Apr; 19(4):217-26. PubMed ID: 24460701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL; You Z; Gitomer B; Brosnahan G; Torres VE; Chapman AB; Perrone RD; Steinman TI; Abebe KZ; Rahbari-Oskoui FF; Yu ASL; Harris PC; Bae KT; Hogan M; Miskulin D; Chonchol M
    J Am Soc Nephrol; 2018 Feb; 29(2):571-578. PubMed ID: 29118087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.
    Bae KT; Tao C; Zhu F; Bost JE; Chapman AB; Grantham JJ; Torres VE; Guay-Woodford LM; Meyers CM; Bennett WM;
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):719-25. PubMed ID: 19339416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automatically Detecting Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease on MRI Using Deep Learning.
    Wang SJ; Hu Z; Li C; He X; Zhu C; Wang Y; Sattar U; Bazojoo V; He HYN; Blumenfeld JD; Prince MR
    Tomography; 2024 Jul; 10(7):1148-1158. PubMed ID: 39058059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
    Higashihara E; Yamamoto K; Kaname S; Okegawa T; Tanbo M; Yamaguchi T; Shigemori K; Miyazaki I; Yokoyama K; Nutahara K
    Clin Exp Nephrol; 2019 Jan; 23(1):100-111. PubMed ID: 30097754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression.
    Magistroni R; Corsi C; Martí T; Torra R
    Am J Nephrol; 2018; 48(1):67-78. PubMed ID: 30071518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A follow-up study of autosomal dominant polycystic kidney disease with intracranial aneurysms using 3.0 T three-dimensional time-of-flight magnetic resonance angiography.
    Jiang T; Wang P; Qian Y; Zheng X; Xiao L; Yu S; Liu S
    Eur J Radiol; 2013 Nov; 82(11):1840-5. PubMed ID: 23466029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Semiautomated thyroid volumetry using 3D CT: prospective comparison with measurements obtained using 2D ultrasound, 2D CT, and water displacement method of specimen.
    Lee SJ; Chong S; Kang KH; Hur J; Hong BW; Kim HJ; Kim SJ
    AJR Am J Roentgenol; 2014 Nov; 203(5):W525-32. PubMed ID: 25341167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI in autosomal dominant polycystic kidney disease.
    Zhang W; Blumenfeld JD; Prince MR
    J Magn Reson Imaging; 2019 Jul; 50(1):41-51. PubMed ID: 30637853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reproducibility and repeatability of volumetric measurements for olfactory bulb volumetry: which method is appropriate? An update using 3 Tesla MRI.
    Burmeister HP; Baltzer PA; Möslein C; Bitter T; Gudziol H; Dietzel M; Guntinas-Lichius O; Kaiser WA
    Acad Radiol; 2011 Jul; 18(7):842-9. PubMed ID: 21669350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.